Certified by Founder Lodge
Cathay Health
France - Paris
INVESTOR
1 Disclosed Funding Rounds $31,300,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Cathay Health, affiliated to Cathay Capital, is a global fund investing at the convergence of healthcare, life sciences and technology.
We back venture to growth-stage companies across Eu
| Company | Date | Round | Raised |
|---|---|---|---|
 Moon Surgical |
June, 30 ,2022 | Series A | $31,300,000 |
 Ascend Gene & Cell Therapies |
May, 10 ,2023 | Series A | $132,500,000 |
 TISSIUM |
May, 23 ,2023 | Series D | $50,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
